📉 Hypomagnesemia

Recognition and Management of Magnesium Deficiency

Visual reference

Magnesium: The Link to Potassium, Calcium, and Rhythm visual summary. Open for the full image and text version.
Magnesium: The Link to Potassium, Calcium, and Rhythm: full graphic and text version

Browse the visual reference library · Download lesson Markdown

🚨 EMERGENCY RECOGNITION: Hypomagnesemia

1 Clinical Suspicion: Tetany, seizures, or torsades de pointes with normal Ca/K levels
2 High-Risk Patients: Chronic alcoholism, diuretics, PPI use, malabsorption
3 Associated Deficiencies: Check K, Ca, PO4 - often concurrent (60% hypokalemic)
4 Treatment Priority: Must correct Mg FIRST - K refractory until Mg repleted

📊 Definition and Clinical Significance

Hypomagnesemia Definition

  • Serum Magnesium: <1.8 mg/dL (0.75 mmol/L)
  • Mild: 1.2-1.8 mg/dL (0.5-0.75 mmol/L)
  • Moderate: 0.8-1.2 mg/dL (0.35-0.5 mmol/L)
  • Severe: <0.8 mg/dL (<0.35 mmol/L)
  • Critical Insight: Normal serum levels don't exclude total body depletion
  • Prevalence: 2-15% hospitalized, up to 65% ICU patients

🎯 Causes of Hypomagnesemia

Category Specific Causes Key Clinical Features Mechanism
Nutritional/GI Chronic alcohol use disorder Multiple nutrient deficiencies, withdrawal risk ↓Absorption, ↑losses, poor intake
Malabsorption syndromes Diarrhea, weight loss, steatorrhea ↓Intestinal absorption
Bariatric surgery (RYGB) Post-surgical, rapid weight loss ↓Absorptive surface area
Renal Losses Loop diuretics Dose-dependent, concurrent hypokalemia ↓TAL reabsorption
Proton pump inhibitors Long-term use (>1 year) ↓TRPM6/TRPM7 channels
Aminoglycosides Duration-dependent nephrotoxicity Tubular toxicity
Endocrine Diabetes mellitus Poor glycemic control, osmotic diuresis ↑Renal losses
Primary aldosteronism Hypertension, concurrent hypokalemia ↑Distal tubule flow
Genetic Gitelman syndrome Hypocalciuria, hypokalemia NCCT mutations

🔍 Clinical Manifestations

Neuromuscular Manifestations

  • Early signs: Fatigue, weakness, irritability
  • Progressive: Muscle cramps, fasciculations
  • Chvostek/Trousseau signs: May be positive
  • Severe: Tetany, seizures, altered mental status
  • Key: Symptoms usually absent until <1.2 mg/dL

Cardiovascular Complications

  • Arrhythmias: Atrial and ventricular
  • Life-threatening: Torsades de pointes
  • Enhanced digitalis toxicity: ↑Na+ cellular accumulation
  • Vascular effects: Coronary spasm, hypertension
  • ECG changes: QT prolongation, U waves

Metabolic Consequences

  • Hypokalemia: 60% of patients concurrent
  • Hypocalcemia: PTH resistance/↓secretion
  • Hypophosphatemia: Impaired PTH action
  • Vitamin D metabolism: ↓1α-hydroxylase activity
  • Insulin resistance: ↓Glucose tolerance

🧮 Hypomagnesemia Risk and Replacement Calculator




Replacement Protocol: Enter values to calculate dosing

🔬 Diagnostic Workup

Initial Laboratory Assessment

  • Serum magnesium (fasting): <1.8 mg/dL diagnostic
  • Ionized magnesium: More accurate but limited availability
  • Concurrent electrolytes: K, Ca, PO4, albumin
  • Intact PTH: Suppressed in severe deficiency
  • 25(OH)D level: Impaired activation

Determine Etiology

  • 24-hour urine Mg: <120 mg/day in deficiency
  • Fractional excretion: >2% suggests renal wasting
  • Medication review: Diuretics, PPIs, antibiotics
  • GI assessment: Diarrhea, malabsorption history

Specialized Testing

  • Mg tolerance test: Gold standard for body stores
  • Genetic testing: Suspected inherited disorders
  • Alcohol use screening: CAGE, quantity assessment
  • Nutritional evaluation: Comprehensive assessment

📐 Fractional Excretion of Magnesium (FEMg)

Formula: FEMg = (UMg × SCr) / (0.7 × SMg × UCr) × 100

  • Normal response to deficiency: <2% (renal conservation)
  • Renal wasting: >2% despite hypomagnesemia
  • Clinical utility: Distinguish renal vs. extrarenal losses

🧪 Ionized Magnesium Testing

  • Normal range: 0.45-0.60 mmol/L
  • Advantages: Not affected by protein binding
  • Clinical utility: Better correlation with intracellular stores
  • Limitations: Limited availability, expensive
  • Consider when: Normal total Mg with strong clinical suspicion
  • Research evidence: May detect deficiency earlier than total Mg

💊 Treatment Strategies

Acute Severe Hypomagnesemia (<1.0 mg/dL)

1 IV Loading Dose: 1-2 grams (4-8 mmol) MgSO4 in 50-100 mL NS over 1-2 hours
2 Continuous Infusion: 6 grams (24 mmol) MgSO4 in 1000 mL NS over 24 hours
3 Monitoring: Serum Mg every 6-8 hours, check DTRs, renal function
4 Concurrent K replacement: Required for successful K repletion

Oral Magnesium Supplementation

  • Preferred forms: Chloride, citrate, gluconate, glycinate
  • Highly recommended: Magnesium chloride (25% elemental, excellent absorption)
  • Avoid: Magnesium oxide (poor absorption, diarrhea)
  • Dosing: 400-800 mg daily elemental Mg, divided doses
  • Duration: Weeks to months depending on etiology
  • Side effects: Diarrhea (dose-limiting, less with chloride form)

Chronic Parenteral Therapy

  • Indications: Malabsorption, ongoing losses
  • Dosing: 2-4 grams MgSO4 weekly or twice-weekly
  • Administration: Outpatient infusion centers
  • Monitoring: Monthly serum levels, clinical symptoms

Treatment of Underlying Conditions

  • Medication review: Discontinue/modify offending agents
  • Alcohol cessation: Comprehensive addiction treatment
  • GI disorders: Specific therapy for malabsorption
  • Endocrine disorders: Hormone replacement/suppression

💊 Oral Magnesium Formulations

Formulation Elemental Mg Content Bioavailability GI Tolerance Clinical Notes
Magnesium Oxide 60% 4% (Poor) Poor - Diarrhea Avoid - despite high Mg content
Magnesium Citrate 16% 25-30% (Good) Good Preferred oral form
Magnesium Gluconate 5.4% 25-30% (Good) Excellent Well tolerated, lower Mg per pill
Magnesium Glycinate 14% 35-40% (Excellent) Excellent Chelated form, optimal absorption
Magnesium Lactate 12% 25-30% (Good) Good Alternative to citrate
Magnesium Chloride 25% 30-35% (Excellent) Very Good Highly bioavailable, well-tolerated

⚠️ Special Clinical Considerations

PPI-Induced Hypomagnesemia

  • Mechanism: ↓TRPM6/TRPM7 intestinal channels
  • Time course: Usually >1 year of therapy
  • High risk: Concurrent thiazides, elderly
  • Management: PPI discontinuation often required
  • Alternatives: H2 blockers don't affect Mg absorption

Alcohol Use Disorder

  • Multiple mechanisms: ↓Intake, ↓absorption, ↑losses
  • Withdrawal risk: ↑Seizure susceptibility
  • Nutritional rehab: Thiamine, folate, B12 deficiencies
  • Higher requirements: During detoxification
  • Comprehensive care: Addiction medicine referral

Diuretic-Induced Deficiency

  • Loop diuretics: Greatest Mg wasting (TAL)
  • Thiazides: Gitelman syndrome phenocopy
  • Dose-dependent: >80 mg furosemide daily high risk
  • Prevention: K-sparing diuretics may help
  • Monitoring: Baseline, 1-2 weeks, then q3-6 months

🔄 Critical Electrolyte Interactions

Magnesium-Potassium Relationship

Intracellular magnesium normally restrains ROMK potassium secretion into urine. Magnesium depletion reduces that inhibition, allowing more potassium loss when distal sodium delivery and ENaC activity provide the driving force. Case 2 has potassium 2.8 and magnesium 1.4.
· Download PNG · Download Markdown · Read text and evidence

Low magnesium can permit ongoing renal potassium loss

  • Physiologic interdependence: Mg deficiency impairs renal K conservation
  • Clinical significance: 60% of hypomagnesemic patients have hypokalemia
  • Treatment priority: Must correct Mg FIRST - K refractory otherwise
  • Mechanism: ↓Na-K-ATPase activity, ↑K channel activity
  • Dosing: Simultaneous replacement more effective than sequential

Magnesium-Calcium-PTH Axis

  • PTH synthesis: Mg required for hormone production
  • PTH secretion: Severe Mg deficiency (<1.0 mg/dL) suppresses PTH
  • PTH resistance: ↓Target organ responsiveness in Mg deficiency
  • Vitamin D metabolism: Mg cofactor for 1α-hydroxylase
  • Clinical result: Hypocalcemia refractory to Ca replacement until Mg corrected

📊 Monitoring and Follow-up

Acute Treatment Monitoring

  • Serum Mg: Every 6-8 hours during IV replacement
  • Renal function: Creatinine, avoid overload
  • Deep tendon reflexes: Clinical improvement marker
  • Cardiac monitoring: If arrhythmias present

Chronic Management

  • Target level: >1.8 mg/dL, ideally 2.0-2.4 mg/dL
  • Follow-up frequency: Weekly initially, then monthly
  • Symptom assessment: Muscle cramps, weakness resolution
  • Concurrent electrolytes: K, Ca, PO4 normalization

🎯 Key Learning Points

  • Recognition: Consider in alcohol use disorder, chronic diuretics, PPI therapy, malabsorption
  • Clinical Clues: Refractory hypokalemia, unexplained tetany, torsades de pointes
  • Diagnostic Limitation: Normal serum Mg doesn't exclude total body depletion
  • Treatment Priority: Must correct magnesium BEFORE potassium will respond
  • Oral Forms: Chloride, citrate, gluconate, glycinate preferred; avoid oxide
  • IV Replacement: 1-2g loading dose, then 6g/24h for severe deficiency
  • PPI Association: Long-term PPI use can cause refractory hypomagnesemia
  • Electrolyte Interactions: Affects K, Ca, PO4 - comprehensive replacement needed
  • Prevention: Monitor high-risk patients, consider prophylactic supplementation